(Total Views: 498)
Posted On: 03/30/2025 10:29:47 AM
Post# of 156229
369P - Observed survival following treatment with Leronlimab in patients with metastatic Triple-Negative Breast Cancer (mTNBC). (ID 1079)
Lecture Time
12:00 - 12:00
Speakers
Richard G. Pestell (Philadelphia, United States of America)
https://cslide.ctimeetingtech.com/breast2025/...session/52
Will the abstract show up on here?
Lecture Time
12:00 - 12:00
Speakers
Richard G. Pestell (Philadelphia, United States of America)
https://cslide.ctimeetingtech.com/breast2025/...session/52
Will the abstract show up on here?
(3)
(0)
Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
